Fate Therapeutics Inc (FATE) support and resistance · rev $3.4M
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
This page maps Fate Therapeutics Inc (FATE) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported FATE revenue for 2026-06-30 was $3.4M. Net income was -$61.4M. FATE currently screens at market cap $331.0M.
FATE currently screens at market cap $331.0M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new FATE 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the FATE quote page for the session range and the stock page for the full model.
Not investment advice.